Business
Beyond blame: The systemic crisis in Sri Lanka’s medicine regulation
The recent suspension of ten Indian-manufactured injections by Sri Lanka’s medicines regulator has done more than ignite a fresh “substandard medicines” scare. It has laid bare a chronic, systemic failure in the nation’s pharmaceutical governance – a failure that transcends political parties and individual ministers.
According to Ravi Kumudesh, President of the Academy of Health Professionals (AHP), this episode is not an isolated scandal but the latest symptom of a regulatory regime that operates on personality and discretion rather than transparent, evidence-based science.
The public’s current anxiety, Kumudesh argues, stems from a dangerous confluence: an allegation of microbial contamination in an injectable, the blanket suspension of ten products from one manufacturer, and the opaque controversy surrounding an “Indian Pharmacopoeia” agreement. “When these three collide,” he states, “the outcome is predictable: not clarity, not confidence – but a national regulatory regime that the public is asked to ‘trust’ without being given the evidence required to trust.”
A problem rooted in system, not scapegoats
Kumudesh insists that framing this crisis around former Health Minister Keheliya Rambukwella or the current minister, Dr. Nalinda Jayatissa, misses the fundamental point. The core issue is a system that has remained stubbornly unchanged across administrations. “The public has watched governments change while the internal decision-making circle inside the regulatory system appears to remain remarkably stable,” he observes. This creates a perilous pattern where the same insiders sometimes act as public critics and at other times as ‘story managers’ within the system, leading to public perception of a credibility gap that no mere statement can bridge.
From hospital test to national edict: A question of protocol
The central controversy, Kumudesh explains, is not the precautionary suspension itself but the evidence pathway that led to it. “A hospital laboratory can detect signals. But national regulatory action requires national-level validation,” he emphasises. The critical, uncomfortable questions he raises are: If Sri Lanka’s own national medicine quality laboratory still lacks full public confidence, how can a hospital test justify a nationally consequential suspension? And if subsequent international or confirmatory tests contradict the initial finding, who repairs the shattered trust and clinical disruption?
He warns that Sri Lanka has seen this movie before – products removed amid public alarm only to be reintroduced later, creating clinical chaos and eroding faith. “Regulatory panic creates clinical chaos,” Kumudesh notes. The proper response to a contamination allegation, he outlines, is systematic: isolate temporarily, collect samples under strict chain-of-custody, and verify through recognised reference testing – not “suspend and shout.”
The unanswered questions: Procurement and agreements
Kumudesh points to glaring gaps in public accountability. One key question remains unanswered: were pre-shipment test reports for these injections reviewed? “If yes: where are the reports? If no: how did the system allow high-risk products in?” he asks, stressing that procurement is a patient-safety responsibility, not mere paperwork.
Furthermore, the shadow over the reported “Indian Pharmacopoeia” agreement exemplifies the systemic opacity. “If an agreement exists, the first duty is public disclosure,” he asserts. Without it, the public cannot assess whether Sri Lanka is strengthening its standards or inadvertently weakening its own scrutiny and liability pathways.
The path forward: Evidence over emotion
For Kumudesh, the solution lies in a radical shift from personality-based to evidence-based regulation. “Committees do not fix systems – systems fix systems,” he says, critiquing the cyclical political response of appointing committees after each crisis. His prescription is structural:
= Establish a stable, transparent regulatory protocol immune to political or personal influence.
= Build a credible, independent national medicine quality laboratory with recognised competency.
= Enforce a clear, legally sound evidence pathway for all regulatory decisions.
= Ensure routine publication of key regulatory outcomes and decisions.
“Without a credible national laboratory,” he warns, “Sri Lanka remains permanently dependent on foreign timelines and credibility, while its own decisions are perpetually questioned.”
The ultimate question Kumudesh leaves for policymakers and the public is stark: “Is the fear of substandard medicines being used to protect patients – or to hide the system’s inability to prove the truth quickly, transparently, and credibly?” Until the architecture of regulation is rebuilt on the bedrock of science and transparency, he concludes, this crisis will not be the last. It will simply be the latest in a long line of failures that place patients and professionals in the crossfire of a system they cannot trust.
By Sanath Nanayakkare ✍️
Business
SL confronting ‘decisive test of fiscal discipline’
Sri Lanka enters the new year confronting a familiar but deepening economic strain, with falling foreign reserves, a weakening rupee, rising public debt and mounting disaster-related losses posing what analysts describe as a decisive test of fiscal discipline and policy coherence.
Sri Lanka Human Rights Centre Executive Director and former Provincial Governor Ranjith Keerthi Tennakoon has warned that the country urgently requires a coordinated economic response to prevent further deterioration, particularly as the cost of post-disaster reconstruction threatens to exert fresh pressure on already strained public finances.
“While the government has succeeded in revenue augmentation through heavy taxation and repeated increases in electricity and gas tariffs, its performance in maintaining fiscal discipline remains weak,” Tennakoon said in an economic indicators statement issued on January 5.
According to figures cited by Tennakoon, Sri Lanka’s domestic debt stood at Rs. 17,595.05 billion when President Anura Kumara Dissanayake assumed office. By the end of September 2025, that figure had climbed to Rs. 18,701.46 billion, reflecting an increase of Rs. 1,106.41 billion within a year.
External debt has also trended upward. From Rs. 10,429.04 billion at the end of 2024, foreign debt rose to Rs. 10,974.34 billion by September 2025. As a result, Sri Lanka’s total public debt stock now stands at Rs. 29,675.81 billion, underscoring the scale of the country’s fiscal exposure.
“This trajectory raises serious concerns about long-term debt sustainability,” Tennakoon warned, noting that debt servicing costs will intensify further if currency depreciation continues.
Foreign reserves under pressure
The steady decline in foreign reserves remains one of the most critical challenges facing the economy. Gross official reserves fell from USD 6,531 million in March 2025 to USD 6,033 million by the end of November, a contraction of nearly USD 500 million.
Tennakoon cautioned that upcoming reconstruction needs following widespread floods and landslides will necessitate substantial imports of construction materials, machinery and industrial inputs, inevitably drawing down scarce foreign exchange reserves.
Although Sri Lanka managed to maintain a current account surplus in 2024, the balance slipped back into deficit during September and October 2025, before returning to surplus in November. While a surplus is not required at all times, Tennakoon said the November turnaround offered a “cautious but positive signal” regarding the economy’s direction.
The rupee’s depreciation continues to amplify macroeconomic risks. The exchange rate has weakened from Rs. 293.25 per US dollar last year to around Rs. 309.45, increasing the rupee cost of foreign debt servicing while driving up import and production costs.
More troubling, Tennakoon noted, is the widening gap between commercial bank exchange rates and the informal undiyal (black market) rate, reflecting growing uncertainty and eroding confidence.
“This was precisely how the 2021–2022 economic crisis began — with a widening divergence between official and informal exchange rates,” he warned.
The economic fallout from recent floods and landslides adds another layer of urgency. Tennakoon criticised the government for failing, thus far, to prepare a comprehensive estimate of financial losses and reconstruction costs.
Preliminary assessments by the World Bank estimate disaster-related losses at USD 4 billion, while the International Labour Organization (ILO) places the figure as high as USD 16 billion, equivalent to 16 percent of GDP.
“Massive tax resources will be required for relief payments, while reconstruction will demand substantial foreign exchange for imports,” Tennakoon said, stressing that the government must urgently prepare credible financial assessments to mobilise both domestic and international support.
He also warned that delays in providing adequate relief have already become a serious concern for displaced communities struggling to rebuild their lives.
By Ifham Nizam
Business
Driving Growth: SEC and CSE collaborate to expedite listings
The Securities and Exchange Commission of Sri Lanka (SEC) in collaboration with the Colombo Stock Exchange (CSE) conducted an awareness session for Corporate Finance Advisors focusing on enhancing regulatory compliance and streamlining the listing process.
The forum brought together Corporate Finance Advisors and senior officials from the SEC and CSE to enhance the listing process by addressing regulatory expectations, identifying prevalent shortcomings in applications, and establishing best practices to strengthen investor confidence and market integrity.
Addressing the participants, Senior Prof. D.B.P.H. Dissabandara, Chairman, SEC highlighted the vital role Corporate Finance Advisors play in building market confidence beyond their traditional functions in facilitating listings, mergers, and acquisitions.
“Your screening process, your due diligence supports market confidence directly in addition to your key major roles,” the Chairman stated. “As a regulator, our main job is to look at investor confidence plus investor protection. And indirectly your job facilitates that as well.”
The Chairman emphasized that the overall reputation of the Sri Lankan capital market depends on the professional judgment and performance of Corporate Finance Advisors, as investors make decisions based on their assessments and recommendations.

Senior Prof. D.B.P.H. Dissabandara
Reinforcing this message, Mr. Rajeeva Bandaranaike, Chief Executive Officer, CSE emphasized the importance of collaboration in improving market efficiency. “The objective is to completely revamp and improve the overall listing experience for companies and issuers,” he stated. “This is a journey that we need to go together with the community. We cannot do this alone.”
He also noted the complexity of public listings compared to bank financing, explaining that heightened scrutiny is necessary when dealing with public money. “At the end of the day, if the prospectus is not clean and accurate, we’re going to face problems. We don’t want companies going into the watchlist after one or two months of listing.”
Building on this framework, Ms. Kanishka Munasinghe, Vice President, Listing, CSE highlighted critical gaps in recent listing applications, particularly regarding litigation disclosure and legal due diligence. The CSE has expanded its disclosure requirements to cover not just financial impact but also operational continuity and licensing implications.
Business
nVentures leads US $200K seed round into Flash Health to scale cashless outpatient care in Sri Lanka
Flash Health, a Sri Lankan healthtech startup building cashless, on-demand outpatient care, has raised a US $200,000 seed round led by nVentures, with participation from angel investors across Sri Lanka, Singapore, and the United States.
The funding comes as Flash Health expands its footprint across insurers, large employers, and healthcare providers, positioning itself as one of the country’s most widely adopted digital outpatient platforms addressing everyday healthcare needs.
At the core of Flash Health’s offering is Cashless OPD, which allows employees and policyholders to access doctor consultations, medicines, diagnostics, and telemedicine services without paying out of pocket, removing upfront payments and simplifying access to address a long-standing friction point in everyday healthcare across emerging markets. The platform’s approach has also received global recognition, with Cashless OPD winning at the World Summit Awards, an UN-backed platform recognising startups advancing the Sustainable Development Goals, selected from over 900 applications across 143 countries. Commenting on the investment, Chalinda Abeykoon, Managing Partner at nVentures, said, “We first met Arshad and the Flash Health team in late 2023 and were immediately struck by their ethos, attention to detail, and culture of excellence. As we worked with the team to fine-tune their product roadmap and execution, we saw a team that listens, iterates, and delivers. Flash Health is now operating at real scale, which made this a clear investment decision for us.”
Flash Health’s growth has been driven by partnerships with leading insurance providers, including AIA, HNB Assurance, Janashakthi Insurance, and Union Assurance, enabling policyholders to access services such as medicine delivery, home lab testing, telemedicine consultations, and wellness incentives through integrated digital workflows.
-
News1 day agoBroad support emerges for Faiszer’s sweeping proposals on long- delayed divorce and personal law reforms
-
News2 days agoPrivate airline crew member nabbed with contraband gold
-
News1 day agoInterception of SL fishing craft by Seychelles: Trawler owners demand international investigation
-
News4 days agoHealth Minister sends letter of demand for one billion rupees in damages
-
Opinion6 days agoRemembering Douglas Devananda on New Year’s Day 2026
-
Features2 days agoPharmaceuticals, deaths, and work ethics
-
News1 day agoUS raid on Venezuela violation of UN Charter and intl. law: Govt.
-
Features1 day agoEducational reforms under the NPP government
